Checkpoint Capital L.P. Immunocore Holdings PLC Transaction History
Checkpoint Capital L.P.
- $182 Billion
- Q1 2025
A detailed history of Checkpoint Capital L.P. transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Checkpoint Capital L.P. holds 9,011 shares of IMCR stock, worth $283,756. This represents 0.15% of its overall portfolio holdings.
Number of Shares
9,011Holding current value
$283,756% of portfolio
0.15%Shares
1 transactions
Others Institutions Holding IMCR
# of Institutions
128Shares Held
44.6MCall Options Held
219KPut Options Held
125K-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.05MShares$222 Million0.14% of portfolio
-
Wellington Management Group LLP Boston, MA6.13MShares$193 Million0.04% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$153 Million2.37% of portfolio
-
Primecap Management CO Pasadena, CA2.68MShares$84.4 Million0.07% of portfolio
-
Baker Bros. Advisors LP New York, NY2.32MShares$73.1 Million0.82% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.38B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...